Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The expanding spectrum of biological actions of vitamin D.
Rojas-Rivera J, De La Piedra C, Ramos A, Ortiz A, Egido J. Rojas-Rivera J, et al. Nephrol Dial Transplant. 2010 Sep;25(9):2850-65. doi: 10.1093/ndt/gfq313. Epub 2010 Jun 3. Nephrol Dial Transplant. 2010. PMID: 20525641 Review. No abstract available.
Vitamin D receptor activation and cardiovascular disease.
Gonzalez-Parra E, Rojas-Rivera J, Tuñón J, Praga M, Ortiz A, Egido J. Gonzalez-Parra E, et al. Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv17-21. doi: 10.1093/ndt/gfs534. Nephrol Dial Transplant. 2012. PMID: 23258805 Review.
Use of sevelamer in chronic kidney disease: beyond phosphorus control.
Rodríguez-Osorio L, Zambrano DP, Gracia-Iguacel C, Rojas-Rivera J, Ortiz A, Egido J, González Parra E. Rodríguez-Osorio L, et al. Nefrologia. 2015;35(2):207-17. doi: 10.1016/j.nefro.2015.05.022. Epub 2015 Jun 23. Nefrologia. 2015. PMID: 26300515 Free article. Review. English, Spanish.
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.
Rojas-Rivera J, Fernández-Juárez G, Ortiz A, Hofstra J, Gesualdo L, Tesar V, Wetzels J, Segarra A, Egido J, Praga M. Rojas-Rivera J, et al. Clin Kidney J. 2015 Oct;8(5):503-10. doi: 10.1093/ckj/sfv075. Epub 2015 Sep 24. Clin Kidney J. 2015. PMID: 26413273 Free PMC article.
Atrasentan for the treatment of diabetic nephropathy.
Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E, Gomez-Guerrero C. Egido J, et al. Expert Opin Investig Drugs. 2017 Jun;26(6):741-750. doi: 10.1080/13543784.2017.1325872. Expert Opin Investig Drugs. 2017. PMID: 28468519 Review.
37 results